TP Therapeutics is a clinical-stage structure-based drug design company that discovers and develops precision medicines for cancer and other diseases. The company is focusing on the design of novel chemical identities for established oncogene drivers with secondary resistant mutations, newly identified disease-driven targets, and potential targets regulating tumor microenvironment and tumor immunity.
|HQ||San Diego, US||Map|
Net income (Q2, 2020)
EBIT (Q2, 2020)
Market capitalization (15-Sept-2020)
Closing stock price (15-Sept-2020)
TP Therapeutics has 193 Twitter Followers. The number of followers has increased 6.5% month over month and increased 19.8% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was TP Therapeutics founded?
TP Therapeutics was founded in 2013.
Who are TP Therapeutics key executives?
TP Therapeutics's key executives are Homa Yeganegi, Athena M. Countouriotis and Annette North.
How many employees does TP Therapeutics have?
TP Therapeutics has 102 employees.
Who are TP Therapeutics competitors?
Competitors of TP Therapeutics include Humanetics, NATCO Pharma and Helsinn Group.
Where is TP Therapeutics headquarters?
TP Therapeutics headquarters is located at 10628 Science Center Dr #225, San Diego.
Where are TP Therapeutics offices?
TP Therapeutics has an office in San Diego.
How many offices does TP Therapeutics have?
TP Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies